Broadlane Inc and Biosite Incorporated have signed a three-year purchasing agreement to provide Broadlane''s customers with reagents and equipment for natriuretic peptide testing. Additionally, Biosite will offer its Triage Cardiac Panel and Triage TOX Drug Screen to Broadlane customers.

Under the terms of the agreement, Biosite will offer Broadlane customers preferred pricing for the Triage BNP Test, which aids in the detection of congestive heart failure. The comprehensive agreement also covers the Triage Cardiac Panel, Triage TOX Drug Screen, Triage MeterPlus, Triage Census Data Management System, laboratory information system integration services and a full range of ENCOMPASS customer support programs.

Biosite was awarded the contract as part of Broadlane''s intensive contract selection process, which focuses on delivering high-quality, cost-effective products and services to Broadlane''s healthcare provider customers. To ensure that it selects the best products and vendors for its customers, Broadlane solicits input and direction from key end users, such as physicians and nurses, as well as hospital business leaders.

Suppliers find particular value in contracting with Broadlane because of the company''s strategy of involving clinical end users from the beginning of the contracting process. That means that buyers ultimately have a much deeper commitment to the contracts than is typical.